GRP
ACTU

Global Retirement Partners’s Actuate Therapeutics ACTU Stock Holding History

Global Retirement Partners’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$38.3K Hold
6,250
– – ﹤0.01% 2512
2025
Q3 		$41.8K Hold
6,250
– – ﹤0.01% 1998
2025
Q2 		$38.2K Buy
+6,250
New +$54.6K ﹤0.01% 1925

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Global Retirement Partners's ACTU Position: Q4 2025 in Review

Global Retirement Partners held its Actuate Therapeutics (ACTU) position steady in Q4 2025 at 6,250 shares worth $38.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

Global Retirement Partners first reported a position in ACTU in Q2 2025 and has held it in 3 quarters since. The position peaked at $41.8K in Q3 2025. 45 funds tracked by Wall St. Rank hold ACTU as of Q4 2025.

  • Global Retirement Partners held 6,250 shares of Actuate Therapeutics worth $38.3K as of Q4 2025.
  • Global Retirement Partners left its Actuate Therapeutics share count unchanged in Q4 2025.
  • Actuate Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2512 holding.
  • Global Retirement Partners first reported a position in Actuate Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • Global Retirement Partners's Actuate Therapeutics position peaked at $41.8K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.